January 25 - 27, 2010, The Ritz Carlton, Philadelphia, PA
Register by Dec 04, 2009 and receive up to $698 off!
Download the Brochure
Chris Thomson PhD, Director of Licensing & Business Development at Astellas Pharma Europe Ltd on The Changing Fortunes of Antibacterial Drug Development and Commercialization
Sustained Release of Nitric Oxide from the Hybrid Nanoparticle Platform: A Novel Therapeutic Strategy for Cutaneous Infections with Dr. Adam Friedman
Visit the Download Center to check Speaker Submissions and past Attendees
Become a Pharma IQ Member and receive our weekly newsletter!
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
David J. Payne
PhD, Vice President Antibacterial DPU, Infectious Diseases Center of Excellence in Drug Discovery
PhD, Director, Licensing & Business Development
Astellas Pharma Europe Ltd
MD, Senior Medical Director
Astellas Pharma US
Neil D. Pearson
PhD, Director Medicinal Chemistry, Antibacterial DPU, Infectious Diseases Center of Excellence in Drug Discovery
PhD, Chief Scientific Officer
Ly Tam Phan
PhD, Senior Director Medicinal Chemistry
Enanta Pharmaceuticals Inc.
PhD, Executive Director, Anti-Bacterials
MD, Chief Resident, Department of Medicine, Division of Dermatology
Albert Einstein College of Medicine
DVM, PhD, Gastroenteritis & Respiratory Viruses Lab Branch
Centers for Disease Control and Prevention
[ Register Now ]
Questions about IQPC's Conferences, Events or Training Seminars? Contact us on 1-800-882-8684 or email email@example.com now!